Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eaton, M. L.
Right arrow Articles by Niewoehner, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eaton, M. L.
Right arrow Articles by Niewoehner, D. E.

Chest, Vol 82, 538-542, Copyright © 1982 by American College of Chest Physicians

ARTICLES

Effects of theophylline on breathlessness and exercise tolerance in patients with chronic airflow obstruction

ML Eaton, FM MacDonald, TR Church and DE Niewoehner

Theophylline is commonly prescribed for patients with nonasthmatic chronic airflow obstruction (CAO) even though clinical efficacy is not well established. We studied objective and subjective responses to theophylline in 14 men with CAO. Subjects randomly received week-long treatments of placebo or theophylline at two dosages: one that produced low (8.7-13.0 micrograms/ml) and the other high (16.0-23.6 micrograms/ml plasma concentrations. During the final three days of each treatment, we measured spirometric and hemodynamic function. Exercise tolerance was assessed with the 12 minute walk and progressive cycle ergometry. The patients' perception of breathlessness during the usual activities of daily living was evaluated with the oxygen cost diagram and the breathlessness rating. For low and high dose theophylline there were significant (p less than .05) increases in forced vital capacity (7.1 +/- 2.1 percent; 12.0 +/- 1.7 percent), forced expiratory volume at one second (14.6 +/- 4.9 percent; 12.1 +/- 3.3 percent) and in pulse rate (8.3 +/- 1.2 percent; 19.1 +/- 3.1 percent), but no changes in blood pressure. There were also no significant differences among the three treatments for any of the tests which assessed exercise tolerance or breathlessness. These results suggest that most patients with CAO experience little symptomatic benefit from taking theophylline.


This article has been cited by other articles:


Home page
 ChestHome page
J. J. W. Liesker, P. J. Wijkstra, N. H. T. Ten Hacken, G. H. Koeter, D. S. Postma, and H. A. M. Kerstjens
A Systematic Review of the Effects of Bronchodilators on Exercise Capacity in Patients With COPD
Chest, February 1, 2002; 121(2): 597 - 608.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. L. Mahon, A. Laupacis, R. V. Hodder, D. A. McKim, N. A. M. Paterson, T. E. Wood, and A. Donner
Theophylline for Irreversible Chronic Airflow Limitation: A Randomized Study Comparing n of 1 Trials to Standard Practice
Chest, January 1, 1999; 115(1): 38 - 48.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M. Tsukino, K. Nishimura, A. Ikeda, T. Hajiro, H. Koyama, and T. Izumi
Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease
Thorax, April 1, 1998; 53(4): 269 - 273.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by the American College of Chest Physicians.